Berrin Ceyhan

Berrin Ceyhan

Auto-generated profile, based on publicly available information

Berrin Ceyhan

Department of Pulmonary Medicine and Intensive Care, Faculty of Medicine, Marmara University, 34890 Istanbul, Türkiye

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2020 in Tuberk Toraks
Verified
Journal Article
Open access
MBMelahat Beki̇r
Melahat Beki̇r
DKDerya Kocakaya
Derya Kocakaya
BBBaran Balcan
Baran Balcan
SYSehnaz Olgun yildizeli
Sehnaz Olgun yildizeli
EEEmel Eryüksel
Emel Eryüksel
BCBerrin Ceyhan
Berrin Ceyhan
Bronchiectasis is a chronic suppurative disease characterized by abnormal bronchial dilatation. The nature of bronchiectasis may have negative impact on psychological status, however it is poorly studied in relation to clinical indices, particularly the severity of disease. Primary aim of this study is to detect depression and anxiety in patients with non-cystic fibrosis bronchiectasis and to evaluate its relationship with disease severity indexes. Ninety (male/female= 37/53; median age 45 years) stable non-cystic fibrosis bronchiectatic adult patients were enrolled into this study. Dyspnea scores, number of exacerbations and hospital admissions within the last year, body-mass index, pulmonary function tests, sputum cultures, bronchiectasis disease severity indexes (BSI and FACED) were assessed. Anxiety and depression were evaluated by using the Turkish version of the hospital anxiety and depression scale questionaire. Anxiety was diagnosed in 30% of patients and depression was diagnosed in 41% of the participants. Female participants had significantly higher rates of depression (55% vs. 22%; p= 0.002). Exacerbation rates within the last year were higher among the subjects with anxiety, moreover, patients with depression had shorter duration of disease. BSI and FACED severity indexes increased with longer duration of disease (5.6 ± 5.0 yrs in mild group vs. 10.1 ± 9.2 yrs in moderate-to-severe group, p= 0.035 and 5.7 ± 5.4 yrs in mild group vs. 12.1 ± 9.7 yrs in moderate-to-severe group, p= 0.001, respectively), however, anxiety and depression were not related with BSI and FACED severity indexes. Patients with non-cystic fibrosis bronchiectasis have an increased risk for depression and anxiety. Duration of disease and higher exacerbation rate are related with psychological status and indexes increased with longer duration of disease. Early detection and taking the necessary measures to improve the psychological state is necessary for the overall management of these patients.

21 January 2022 in Turkish Thoracic Journal
Verified
Journal Article
Open access
BCBerrin Ceyhan
Berrin Ceyhan
MBMelahat Bekir
Melahat Bekir
DKDerya Kocakaya
Derya Kocakaya
SYSehnaz Olgun yildizeli
Sehnaz Olgun yildizeli
SESemiha Emel Eryüksel
Semiha Emel Eryüksel
Depression,anxiety,quality of life,non-CF bronchiectasis

12 February 2021 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
MBMelahat Bekir
Melahat Bekir
EKElif Karakoc-Aydıner
Elif Karakoc-Aydıner
SYSehnaz Olgun yildizeli
Sehnaz Olgun yildizeli
IÖIsmail Öğülür
Ismail Öğülür
DKDerya Kocakaya
Derya Kocakaya
BCBerrin Bağcı Ceyhan
Berrin Bağcı Ceyhan
Bronchiectasis is characterized by chronic respiratory infection. The role of immunodeficiency in this disease is poorly studied in relation to clinical indices. The primary aim of this study was to determine the frequency of these neglected altered immune status by evaluating immunoglobulins, lymphocyte subsets, complement levels, and neutrophil function, and to assess its relationship with clinical parameters in adult patients with non-cystic fibrosis bronchiectasis (NCFB). A total of 74 (30 men and 44 women with a mean age of 47±17 years) adult patients with stable NCFB were enrolled in this study. The bronchiectasis severity index (BSI) and FACED (F:FEV1, A: Age, C: Chronic colonization, E: Extension, D: Dyspnea) scores were assessed. Peripheral blood samples were collected for the detection of total IgG, IgA, IgM, IgE, and IgG subclasses and C3 and C4 levels. The counts of CD3, CD4, CD8, CD19, CD16/56 expressing peripheral blood lymphocytes and neutrophil oxidative function were evaluated. In the study population, BSI and FACED severity index scores increased with longer duration of the disease (p=0.01 and p=0.040, respectively). Of the 74 patients, 27 (37%) showed humoral aberrations. The number of male patients were higher in this group (p=0.03). High serum total IgE levels were associated with high scores in BSI (moderate-severe group versus mild group, p=0.030). Patients with bronchiectasis demonstrated lower CD3+ T cell count, lower CD4+ T helper cell percentage, and lower CD4+ T cell count (p=0.031, p=0.030, p=0.029, respectively) than healthy subjects. A significant negative correlation was found between the percentage and count of CD16/56+ natural killer (NK) cells and the number of exacerbations within the past year (r=-0.230, p=0.049 and r=-0.264, p=0.023, respectively). Humoral aberrations in adult patients with NCFB were found to be frequent. IgE levels were related to high scores for disease severity indices. Furthermore, patients with low percentage and counts of NK cells had higher rates of exacerbations. These results emphasize the importance of immune function assessment in adult patients with NCFB.

2 August 2024 in Thoracic Research and Practice
Verified
Journal Article
Open access
BCBerrin Ceyhan
Berrin Ceyhan
ZSZeynep Uslu Suner
Zeynep Uslu Suner
DKDerya Kocakaya
Derya Kocakaya
SYSehnaz Olgun yildizeli
Sehnaz Olgun yildizeli
EEEmel Eryüksel
Emel Eryüksel
Anxiety,depression,cystic fibrosis,quality of life,coping

2 December 2022 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
NUNazlı Zeynep Uslu
Nazlı Zeynep Uslu
DKDerya Kocakaya
Derya Kocakaya
SYSehnaz Olgun yildizeli
Sehnaz Olgun yildizeli
EEEmel Eryüksel
Emel Eryüksel
OKOzge Kenis
Ozge Kenis
BCBerrin Ceyhan
Berrin Ceyhan
Objectives: This study aimed to evaluate the muscle thickness, strength, and diaphragmatic function and relate them with clinical findings. Patients and methods: The cross-sectional study was conducted with 54 participants (27 males, 27 females; mean age; 24.5±5.3 years; range, 18 to 45 years) between January 2017 and October 2017. Of the participants, 31 were adult CF patients, and 23 were age-and sex-matched controls. Patient demographics, 6-min walk distance, body mass index (BMI), and fat-free mass index (FFMI) were evaluated. Each patient underwent pulmonary function tests. Quadriceps femoris thickness and diaphragm thickening fraction were assessed by ultrasonography. Upper extremity strength was measured with a handheld dynamometer. Results: There was no difference between the patients’ and controls’ BMI (p=0.052). However, patients’ FFMI was lower than the controls’ (p=0.010). The FFMI correlated with pulmonary function tests. Patients’ both right and left quadriceps femoris muscles were thinner than the controls (p=0.001 and p=0.001, respectively). Patients with pancreatic insufficiency had thinner muscles than patients without pancreatic insufficiency. The control group had a stronger handgrip than CF patients (33.5±10.1 vs. 24.5±9.2 kg, p=0.003). Conclusion: Peripheral muscle wasting and weakness and lower functional capacity are highly prevalent in CF patients.

29 December 2017 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
TOTunc Ones
Tunc Ones
EEEmel Eryuksel
Emel Eryuksel
FBFeyyaz Baltacioglu
Feyyaz Baltacioglu
BCBerrin Ceyhan
Berrin Ceyhan
TETanju Yusuf Erdil
Tanju Yusuf Erdil
Selective internal radiation therapy (SIRT) with embolization of branches of the hepatic artery is a valuable therapeutic tool for patients with hepatic malignancies; however, it is also associated with lung injury risk due to shunting. Diffusion capacity of the lungs for carbon monoxide (DLCO) is a clinically significant lung function test, and worsening in DLCO is suggested to reflect a limited gas exchange reserve caused by the potential toxicity of chemoradiotherapy or it may be a marker of related lung injury. This study aimed to examine the changes in DLCO during SIRT with resin microspheres in newly treated and retreated patients. Forty consecutive patients who received SIRT for a variety of malignant conditions were included. All subjects were treated with Yttrium-90 labelled resin microspheres. DLCO tests were performed after the procedures. In addition, patients were specifically followed for radiation pneumonitis. The mean DLCO did not significantly change after the first (82.8 ± 19.4 vs. 83.1 ± 20.9, p = 0.921) and the second treatments (87.4 ± 19.7 vs. 88.6 ± 23.2, p = 0.256). Proportion of patients with impaired DLCO at baseline was not altered significantly after the first (37.5 vs. 45.0%, p = 0.581) and the second treatments (27.3 vs. 27.3%, p = 1.000). Also, percent change in DLCO values did not correlate with radiation dose, lung shunt fraction, or lung exposure dose (p > 0.05 for all comparisons). None of the patients developed radiation pneumonitis. Our results suggest that no significant change in DLCO in association with SIRT occurs, both after the first or the second treatment sessions. Further larger studies possibly with different protocols are warranted to better delineate DLCO changes after SIRT in a larger spectrum of patients.